Is CNMD a Buy Now as Low Valuation Meets Persistent Execution Risk?
CONMED Corporation CNMD presents investors with a clear trade-off. The stock's valuation is inexpensive relative to key benchmarks, while operating trends and the 2026 earnings outlook have improved. The offset is execution risk. Cash flow, supply-chain work and higher financing costs still leave limited …